Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Response in Psychosis Study
NCT00314327Phase 4Terminated
- Sponsor
- Northwell Health
- Start
- Apr 2006
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risperidone in schizophrenia, schizoaffective disorder, schizophreniform disorder, psychotic disorder, sponsored by Northwell Health. Started Apr 2006; status: terminated.
02
Drugs
risperidone
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disorderpsychotic disorder
Beyond the preview
Go deeper on NCT00314327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314327.